my question,which i never challenged SW with,is,if this is such a breakthrough,why are a signicant number of researchers in University labs working so hard to find a molecular configuration that will successfully block the cold virus at it's nasal entry,and have yet to nail this down(but are getting ever closer,it seems).
Why do they bother,when Zicam is the answer???
Because they know how much bilge is put out by what is nothing more than "anecdotal evidence"
<<The wild card in the near term is the prophylactic clinical study. If it comes back positive, I believe that the stock will make a new 52 week high within one week of the news release>> the news release to get REAL investors,if one were to come,must contain strongly SIGNICANT positive results and from a lab with impeccable credentials,who have nothing to gain from such a report.
Who is running these clinical trials,i don't know,as i have not been keeping up,just came to the thread,because i had been scanning my "people marks",i saw SW had not posted in a longtime,so dug up his last post,last night--was sad to read,but he went out like a gentleman--which he is.
i am not short the stock,and would not short it,myself,unless i could buy some call insurance(just part of my now personal trading methodology in potentially explosive stocks)--but as i write this post,i do not even know if GUMM has options.max |
